摘要
目的:了解干扰素-α(IFN-α)逆转白血病细胞多药耐药性(MDR)的作用和可能机制。方法:采用链亲和素-胶体金原位杂交(SAG-ISH)检测了IFN-α孵育前后的52例白血病患者骨髓细胞的多药耐药基因(MDR1)表达,用荧光分光光度法测定了IFN-α孵育前后的52例骨髓细胞内柔红霉素(DNR)浓度。结果:全部52例患者中24例(46.2%)MDR1阳性,初治组与复发难治组相比相差显著。MDR1阳性者骨髓细胞内柔红霉素浓度与阴性者相差显著。IFN-α孵育后的MDR1阳性率与孵育前相差不显著,但经IFN-α孵育前后的MDR1阳性者的骨髓细胞内DNR浓度相差显著,阴性者亦然。结论:IFN-α能增加白血病细胞内DNR浓度,其逆转MDR环节不在MDR1基因水平上。
Objective: To investigate the reversing effects of interferon α (IFN α) on drug resistance of bone marrow cells in leukemia and its possible mechanism. Methods: Before and after the bone marrow cells extracted from 50 cases of acute leukemia and 2 of chronic leukemia were incubated in the media with the addition of IFN α, MDR 1 mRNA expression and concentration of daunorubicin (DNR) in the cells were determined respectively with SGA ISH and respectrofluorimetry. Results: Twenty four (46.2%) out of all the 52 cases presented MDR 1 mRNA expression. There was significant difference in the concentration of DNR between MDR 1 positive and MDR 1 negative cases before and after incubation. In all the 52 cases, no significant difference was found between the concentration of DNR before the incubation and that after the incubation. Conclusion: IFN α can increase the concentration of DNR in the bone marrow cells in leukemia. The occurrence of MDR reversal is not on the level of MDR 1 but on other levels.
出处
《第三军医大学学报》
CAS
CSCD
北大核心
1999年第3期153-155,共3页
Journal of Third Military Medical University